Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in patients with type 2 diabetes mellitus and asthma
IRCT2016050827785N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research of Tehran University of Medical Sciences
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone in type 2 diabetes mellitus (T2DM) and asthma, sponsored by Vice Chancellor for Research of Tehran University of Medical Sciences. Started Mar 2015; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)asthma
Beyond the preview
Go deeper on IRCT2016050827785N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016050827785N1.